Cardiology Update India 2022
-
City
Virtual Meeting
Type of event
virtual
Invitation
Dear colleagues
It is a pleasure to announce the 4th Indo-European Cardiology Update to be held on September 10th - 11th, 2022. Based on the tremendous success and wide acclaim for the Cardiology Update 2021, the organizers have assembled a truly spectacular scientific program for this year. The joint Indo-European collaboration in the field of cardiology from prevention to management of coronary disease and heart failure is an important avenue to decrease the chronic disease burden in India.
The proposed scientific agenda includes the latest trends in prevention including lipid disorders and hypertension, acute and chronic coronary syndromes and heart failure based on evidence and the most recent ESC Guidelines which are of paramount importance to the physicians in clinical practice. The course will further include state-of-art presentations by eminent Indian and European faculty members known for their clinical expertise in the most common cardiac conditions.
We are confident that the Indo-European Cardiology Update 2022 will be yet another milestone in professional education and in the annals of preventive cardiology. The attendees will gain additional clinical tools in the early identification of cardiovascular risk factors and in the management of cardiovascular disease in the community.
Best wishes and kind regards,
Thomas F. Lüscher and C. Venkata S. Ram
In collaboration with
Endorsed by:
Programme
Day - 1 Saturday, September 10th, 2020
13:30-17:00 pm (CEST)
| 13:30 – 15:00 Session 1: Dyslipidemia and Prevention Chairpersons: Venkata Ram, Hyderabad/Dallas and Thomas F. Lüscher, London/Zurich |
||
| 13:30-13:45 | Current management of Dyslipidemia: Focus on LDL-Cholesterol | T. Govindan Unni, Thrissur |
| 13:45-14:00 | Lipoprotein(a). The Cinderella of lipid management | Ulf Landmesser, Berlin |
| 14:00-14:15 | Hypertriglyceridemia: Current and future management options | Ulrich Laufs, Leipzig |
| 14:15-14:30 | Comprehensive hypertension management: Initial combination therapy | Venkata Ram, Dallas/Hyderabad |
| 14:30-15:00 | Q&A, Panel Discussion, Audience participation | All Faculty Members |
| 15:00 – 16:30 Session 2: Acute and Chronic Coronary Syndromes Chairpersons: Ulf Landmesser, Berlin and Rajeev Agarwala, Meerut |
||
| 15:00-15:15 | Interventional therapy for chronic coronary syndromes: Current approaches |
Bernard J. Gersh, Rochester MN |
| 15:15-15:30 | Dual antiplatelet therapy in acute and chronic coronary syndromes: Which drug & how long? |
C K Ponde Mumbai / India |
| 15:30-15:45 | Current management of ACS: The ESC Guidelines on STEMI and non STEMI | Holger Thiele, Leipzig |
| 15:45-16:00 | Secondary prevention of coronary syndromes: The ESC Prevention Guidelines | Ajit Mullasari Chennai/India |
| 16:00-16:30 | Q&A, Panel Discussion, Audience participation | All Faculty Members |
| 16:30 | End of Day 1 | |
Day - 2 Sunday, September 11th, 2022
13:30-17:00 (CEST)
|
13:30 – 15:00 Session 3: Arrhythmias and Sudden Cardiac Death |
||
| 13:30-13:45 | Clinical suspicion and diagnosis of atrial fibrillation in clinical practice | Jamshed Dalal, Mumbai |
| 13:45-14:00 | Choice of anticoagulants in atrial fibrillation | A. John Camm, London |
| 14:00-14:15 | Ventricular arrhythmias and sudden cardiac death: The 2022 ESC Guidelines | Bo G. Winkel, Copenhagen |
| 14:15-14:30 | Cardiovascular manifestations of Covid-19 and long Covid | Thomas F. Lüscher, London/Zurich |
| 14:30-15:00 | Q&A, Panel Discussion, Audience participation | All Faculty Members |
| 15:00 - 17:00 Session 4: Heart Failure Chairpersons: Giuseppe Rosano, London and Jamshed Dalal, Mumbai |
||
| 15:00-15:15 | Overview of the 2021 ESC Guidelines on acute and chronic heart failure | Theresa A. McDonagh, London |
| 15:15-15:30 | Selection of beta blockers in the management of cardiovascular disease | K. K. Talwar, Delhi |
| 15:30-15:45 | SGLT2 inhibitors in heart failure: Rationale and results | Milton Packer, Dallas |
| 15:45-16:00 | Managing patients with cancer and heart failure: The 2022 ESC Guidelines | Alexander Lyon, London |
| 16:00-16:30 | Q&A, Panel Discussion, Audience participation | All Faculty Members |
| 16:30-17:00 | Key take home messages, concluding remarks | Venkata Ram, Hyderabad/Dallas Thomas F. Lüscher, London/Zurich |
| 17:00 | End of Day 2 | |